SCHEMBL7703663

SCHEMBL7703663

c1cc(OCCCN2CCCCC2)cc(-c2n[nH]c3c2Cc2ccccc2-3)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 9/20 0.62
KDR P35968 5/20 0.58
HRH3 Q9Y5N1 6/20 0.54
ADORA1 P30542 4/20 0.54
ADORA2A P29274 3/20 0.54
ADORA3 P0DMS8 2/20 0.54
ADORA2B P29275 2/20 0.54
DRD2 P14416 1/20 0.52
DRD3 P35462 1/20 0.52
BACE1 P56817 1/20 0.49
RET P07949 1/20 0.49
PDGFRA P16234 1/20 0.49
CDK2 P24941 1/20 0.49
MARK3 P27448 1/20 0.49
FLT4 P35916 1/20 0.49
RPS6KA3 P51812 1/20 0.49
TYRO3 Q06418 1/20 0.49
CAMK2G Q13555 1/20 0.49
CAMK2D Q13557 1/20 0.49
MELK Q14680 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147015 0.95 KDR (0.59) CHEK1KDRHRH3ADORA1ADORA2A
SCHEMBL7702402 0.94 KDR (0.63) CHEK1KDRHRH3ADORA1ADORA2A
SCHEMBL7700924 0.93 KDR (0.67) CHEK1KDRRETPDGFRACDK2
SCHEMBL7702307 0.92 KDR (0.54) CHEK1KDRHRH3ADORA1ADORA2A
SCHEMBL7702517 0.91 KDR (0.57) CHEK1KDRRETPDGFRACDK2
SCHEMBL7703429 0.91 CHEK1 (0.63) CHEK1KDRRETPDGFRACDK2
SCHEMBL7140591 0.89 KDR (0.64) CHEK1KDRBACE1RETMARK3
SCHEMBL7147004 0.88 KDR (0.68) CHEK1KDRRETPDGFRACDK2
SCHEMBL7703072 0.87 KDR (0.55) CHEK1KDRBACE1RETMARK3
SCHEMBL7172093 0.86 KDR (0.58) CHEK1KDRRETPDGFRACDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed